Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Dabrowska-Iwanicka

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Hematologic Malignancy Reports|June 22, 2014
Primary mediastinal large B-cell lymphomaAnna Dabrowska-Iwanicka, Jan A Walewski
Blood|November 3, 2023
DLBCL: who is high risk and how should treatment be optimized?Anna Dabrowska-Iwanicka, Grzegorz S Nowakowski
Blood|March 5, 2010
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicityJacek Bil, Magdalena Winiarska, Dominika Nowis, et al.
Journal of Cancer Research and Clinical Oncology|August 30, 2002
Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in miceAnna Dabrowska-Iwanicka, Dominika Olszewska, Ahmad Jalili, et al.
Annals of Hematology|October 13, 2010
Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experienceGrzegorz Wladyslaw Basak, Wanda Knopinska-Posluszny, Magdalena Matuszak, et al.
The American Journal of Pathology|June 4, 2010
Cardiotoxicity of the anticancer therapeutic agent bortezomibDominika Nowis, Michał Maczewski, Urszula Mackiewicz, et al.
Scientific Reports|June 22, 2022
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow upJoanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, et al.
Bone Marrow Transplantation|October 2, 2019
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixaforAnna Sureda, Christian Chabannon, Tamás Masszi, et al.
British Journal of Haematology|February 10, 2023
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experienceBeata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, et al.
Mabs|December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Hematologic Malignancy Reports|June 22, 2014
Primary mediastinal large B-cell lymphomaAnna Dabrowska-Iwanicka, Jan A Walewski
Blood|November 3, 2023
DLBCL: who is high risk and how should treatment be optimized?Anna Dabrowska-Iwanicka, Grzegorz S Nowakowski
Blood|March 5, 2010
Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicityJacek Bil, Magdalena Winiarska, Dominika Nowis, et al.
Journal of Cancer Research and Clinical Oncology|August 30, 2002
Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in miceAnna Dabrowska-Iwanicka, Dominika Olszewska, Ahmad Jalili, et al.
Annals of Hematology|October 13, 2010
Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experienceGrzegorz Wladyslaw Basak, Wanda Knopinska-Posluszny, Magdalena Matuszak, et al.
The American Journal of Pathology|June 4, 2010
Cardiotoxicity of the anticancer therapeutic agent bortezomibDominika Nowis, Michał Maczewski, Urszula Mackiewicz, et al.
Scientific Reports|June 22, 2022
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow upJoanna Romejko-Jarosinska, Beata Ostrowska, Anna Dabrowska-Iwanicka, et al.
Bone Marrow Transplantation|October 2, 2019
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixaforAnna Sureda, Christian Chabannon, Tamás Masszi, et al.
British Journal of Haematology|February 10, 2023
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experienceBeata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, et al.
Mabs|December 18, 2014
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska, Kamil Bojarczuk, Beata Pyrzynska, et al.
Pageof 2